| Health Paradigm, Llc | |
|
615 S Trenton St Ruston LA 71270-5040 | |
| (318) 251-2322 | |
| (318) 251-0710 |
| Full Name | Health Paradigm, Llc |
|---|---|
| Speciality | Psychiatry & Neurology |
| Location | 615 S Trenton St, Ruston, Louisiana |
| Authorized Official Name and Position | Elisa M Vandenberg (ADMINISTRATOR) |
| Authorized Official Contact | 3182512322 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Health Paradigm, Llc 615 S Trenton St Ruston LA 71270-5040 Ph: (318) 251-2322 | Health Paradigm, Llc 615 S Trenton St Ruston LA 71270-5040 Ph: (318) 251-2322 |
| NPI Number | 1235340761 |
|---|---|
| Provider Enumeration Date | 05/25/2007 |
| Last Update Date | 09/01/2010 |
| Medicare PECOS PAC ID | 9133397524 |
|---|---|
| Medicare Enrollment ID | O20110801000173 |
News Archive
A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of a double-blind Phase-II trial show.
A study of newly installed, hands-free faucets at The Johns Hopkins Hospital, all equipped with the latest electronic-eye sensors to automatically detect hands and dispense preset amounts of water, shows they were more likely to be contaminated with one of the most common and hazardous bacteria in hospitals compared to old-style fixtures with separate handles for hot and cold water.
A Penn Medicine-developed drug has received orphan status from the Food and Drug Administration (FDA) this month for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis.
SuperGen, Inc. today announced that it has discontinued clinical development of its phase 1 PIM kinase drug candidate, SGI-1776, while continuing development of the PIM inhibitor program.
› Verified 7 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1235340761 | NPI | - | NPPES |
| 1681032 | Medicaid | LA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 101Y00000X | Counselor | CI 3505 LA (Louisiana) | Secondary |
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 1164R (Louisiana) | Primary |
| Provider Name | Herbert Vandenberg |
|---|---|
| Provider Type | Practitioner - Psychiatry |
| Provider Identifiers | NPI Number: 1558397109 PECOS PAC ID: 1557302759 Enrollment ID: I20090928000148 |
News Archive
A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of a double-blind Phase-II trial show.
A study of newly installed, hands-free faucets at The Johns Hopkins Hospital, all equipped with the latest electronic-eye sensors to automatically detect hands and dispense preset amounts of water, shows they were more likely to be contaminated with one of the most common and hazardous bacteria in hospitals compared to old-style fixtures with separate handles for hot and cold water.
A Penn Medicine-developed drug has received orphan status from the Food and Drug Administration (FDA) this month for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis.
SuperGen, Inc. today announced that it has discontinued clinical development of its phase 1 PIM kinase drug candidate, SGI-1776, while continuing development of the PIM inhibitor program.
› Verified 7 days ago
News Archive
A subset of lung cancer patients seem to live longer and experience delays in disease progression when a new drug that targets a cancer-associated molecule called MET is added to treatment with erlotinib, the results of a double-blind Phase-II trial show.
A study of newly installed, hands-free faucets at The Johns Hopkins Hospital, all equipped with the latest electronic-eye sensors to automatically detect hands and dispense preset amounts of water, shows they were more likely to be contaminated with one of the most common and hazardous bacteria in hospitals compared to old-style fixtures with separate handles for hot and cold water.
A Penn Medicine-developed drug has received orphan status from the Food and Drug Administration (FDA) this month for the treatment of paroxysmal nocturnal hemoglobinuria (PNH), a rare, life-threatening disease that causes anemia due to destruction of red blood cells and thrombosis.
SuperGen, Inc. today announced that it has discontinued clinical development of its phase 1 PIM kinase drug candidate, SGI-1776, while continuing development of the PIM inhibitor program.
› Verified 7 days ago
Ruston Behavioral Health Clinic Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 901 White St, Ruston, LA 71270 Phone: 318-251-4125 Fax: 318-251-5000 | |
Lincoln Nova Vital Recovery Center,llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 4396 Highway 80, Ruston, LA 71270 Phone: 318-251-4659 Fax: 318-251-4659 | |
Masterpiece Behavior Services Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2100 Floyd Park Dr Ste 2, Ruston, LA 71270 Phone: 318-548-1589 | |
La Paz, Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 910 S Vienna St Ste 7, Ruston, LA 71270 Phone: 318-278-0309 | |
First Step Counceling Llc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 107 W Alabama Ave, Ruston, LA 71270 Phone: 318-218-2736 | |
People Centered Support Services, Inc. Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 1201 Atkins Road, Ruston, LA 71270 Phone: 318-255-9105 Fax: 318-251-9286 | |
Shreveport Mental Health Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 509 S Barnett Springs St, Ruston, LA 71270 Phone: 318-242-0026 |